<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d332">
    <sentence id="DDI-DrugBank.d332.s0" text="Administration of doxapram to patients who are receiving sympathomimetic or monoamine oxidase inhibiting drugs may result in an additive pressor effect .">
        <entity charOffset="18-25" id="DDI-DrugBank.d332.s0.e0" text="doxapram" type="drug"/>
        <entity charOffset="57-71" id="DDI-DrugBank.d332.s0.e1" text="sympathomimetic" type="group"/>
        <entity charOffset="76-109" id="DDI-DrugBank.d332.s0.e2" text="monoamine oxidase inhibiting drugs" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d332.s0.e0" e2="DDI-DrugBank.d332.s0.e1" id="DDI-DrugBank.d332.s0.p0" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d332.s0.e0" e2="DDI-DrugBank.d332.s0.e2" id="DDI-DrugBank.d332.s0.p1" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d332.s0.e1" e2="DDI-DrugBank.d332.s0.e2" id="DDI-DrugBank.d332.s0.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d332.s1" text="In patients who have received muscle relaxants, doxapram may temporarily mask the residual effects of muscle relaxant drugs.">
        <entity charOffset="30-45" id="DDI-DrugBank.d332.s1.e0" text="muscle relaxants" type="group"/>
        <entity charOffset="48-55" id="DDI-DrugBank.d332.s1.e1" text="doxapram" type="drug"/>
        <entity charOffset="102-122" id="DDI-DrugBank.d332.s1.e2" text="muscle relaxant drugs" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d332.s1.e0" e2="DDI-DrugBank.d332.s1.e1" id="DDI-DrugBank.d332.s1.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d332.s1.e0" e2="DDI-DrugBank.d332.s1.e2" id="DDI-DrugBank.d332.s1.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d332.s1.e1" e2="DDI-DrugBank.d332.s1.e2" id="DDI-DrugBank.d332.s1.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d332.s2" text="In patients who have received general anesthesia utilizing a volatile agent known to sensitize the myocardium to catecholamines, administration of doxapram should be delayed until the volatile agent has been excreted in order to lessen the potential for arrhythmias, including ventricular tachycardia and ventricular fibrillation.">
        <entity charOffset="147-154" id="DDI-DrugBank.d332.s2.e0" text="doxapram" type="drug"/>
    </sentence>
</document>